Statins may lower risk of cancer-related death in women
the ONA take:
According to results of a large study presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, researchers have found that women who take statins, medications used to treat hyperlipidemia, may have a decreased risk for cancer-related death.
For the 15-year study, researchers followed nearly 150,000 post-menopausal women aged 50 to 79 years. Over that period, more than 3,100 women died of cancer. Results showed that women who took statins had a reduced risk of dying from breast, colorectal, and ovarian cancers, but not lung cancer.
Researchers found that patients who took statins were 20% less likely to die from cancer during the study duration; however, they caution that this study does not prove a causal effect that statins reduce the lower the risk cancer-related mortality.
Further studies are warranted to determine whether it would be beneficial for women with cancer to be prescribed statins to reduce their risk of death.
Women who take statins, medications used to treat hyperlipidemia, may have a decreased risk for cancer-related death.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|